In BMJ, Yale University law lecturer Gregg Gonsalves and Diana Zuckerman of the National Center for Health Research argue that the US government has been “chipping away” at the FDA’s powers in order to speed up drug approvals, and the latest proposed bill could roll back patient safeguards by half a century.
Gonsalves, Gregg, and Diana Zuckerman. “Commentary: Will 20th Century Patient Safeguards Be Reversed in the 21st Century?” BMJ 350 (March 25, 2015): h1500. doi:10.1136/bmj.h1500. (Full text)